16th Aug 2005 18:40
GlaxoSmithKline PLC16 August 2005 Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons Following an administrative error in the calculation of the notionalre-investment of the dividend paid to shareholders on 7 July 2005, which theCompany announced on 11 July 2005, the Administrators of the GlaxoSmithKlinePerformance Share Plan notified the Company and the under-mentioned persons on15 August 2005 of a change to their notional interests in Ordinary Shares at aprice of £13.28 per Ordinary Share and Ordinary Share ADRs at a price of $50.03per ADR. The correct increase in the notional interests in Ordinary Shares and OrdinaryShare ADRs is as follows: Dr J P Garnier 3,126.369 ADRs Mr J Heslop 117.838 Ordinary Shares Dr T Yamada 937.911 ADRs Mr R Bondy 1,193.502 Ordinary Shares Mr W Calhoun 390.797 ADRs Mr M Dunoyer 449.501 Ordinary Shares Mr R Greig 390.797 ADRs Mr D Phelan 601.826 ADRs Dr D Pulman 394.878 Ordinary Shares 191.711 ADRs Mr D Stout 1,156.757 ADRs Mr C Viehbacher 601.826 ADRs Mr A Witty 1,051.346 Ordinary Shares Mrs J Younger 271.25 Ordinary Shares Mr J Ziegler 601.826 ADRs The notional dividends accrued will be paid out in proportion to the percentageof participants' Performance Share Plan holdings that vest following the end ofthe relevant three year measurement period. This notification relates to a transaction notified in accordance withDisclosure Rules 3.1.4R(1)(a) and 3.1.4R(1)(b) and replaces RNS Announcement7589O released on 11 July 2005. S M BicknellCompany Secretary 16 August 2005 This information is provided by RNS The company news service from the London Stock ExchangeRelated Shares:
Glaxosmithkline